Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Molecular therapies and metabolomics in albinism
Author Affiliations & Notes
  • Jonathan Zippin
    Weill Cornell Medicine, New York, New York, United States
  • Footnotes
    Commercial Relationships   Jonathan Zippin L'Oreal, Hoth, Code C (Consultant/Contractor), Hoth, Code F (Financial Support), Regeneron, Hoth, Code I (Personal Financial Interest)
  • Footnotes
    Support  NIH/NIAMS 1 R01 AR077664-01A1
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2806. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jonathan Zippin; Molecular therapies and metabolomics in albinism. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2806.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Presentation Description : The presentaiton will review the current state of the art on the use of molecular and and metabolomic approaches to the study of albinism

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×